Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SJF620 hydrochloride is a PROTAC that utilizes a lenalidomide analog to recruit CRBN and ligands to target Btk, exhibiting a DC50 of 7.9 nM [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | SJF620 hydrochloride is a PROTAC that utilizes a lenalidomide analog to recruit CRBN and ligands to target Btk, exhibiting a DC50 of 7.9 nM [1]. |
In vitro | SJF620 hydrochloride functions as a proteolysis-targeting chimera (PROTAC), effectively inducing the degradation of Bruton’s tyrosine kinase (BTK) in cellular assays. It achieves this with a degradation concentration 50 (DC50) of 7.9 nM in the NAMALWA Burkitt lymphoma cell line [1]. |
In vivo | SJF620 hydrochloride demonstrates an excellent pharmacokinetic profile in mice at a dose of 1 mg/kg intravenously, featuring a half-life (t 1/2) of 1.64 hours. Notably, SJF620's pharmacokinetic parameters are significantly superior to those of MT802 [1]. |
Molecular Weight | 797.3 |
Formula | C41H45ClN8O7 |
CAS No. | 2821938-05-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SJF620 hydrochloride 2821938-05-8 PROTAC PROTACs inhibitor inhibit